Skip to main content

Advertisement

ADVERTISEMENT

News

News
03/08/2024
Lisa Kuhns, PhD
Xanax’s effectiveness for treating anxiety may be exaggerated due to publication bias inflating the efficacy, according to a study published in Psychological Medicine.
Xanax’s effectiveness for treating anxiety may be exaggerated due to publication bias inflating the efficacy, according to a study published in Psychological Medicine.
Xanax’s effectiveness for...
03/08/2024
Pharmacy Learning Network

Advertisement

News
03/07/2024
Jolynn Tumolo
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is...
03/07/2024
Pharmacy Learning Network
News
03/07/2024
Jolynn Tumolo
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling...
03/07/2024
Pharmacy Learning Network
News
03/06/2024
Jolynn Tumolo
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed...
03/06/2024
Pharmacy Learning Network

Advertisement

News
03/05/2024
Jolynn Tumolo
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental...
03/05/2024
Pharmacy Learning Network
News
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
03/01/2024
Jolynn Tumolo
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the...
03/01/2024
Pharmacy Learning Network

Advertisement

News
02/29/2024
Jolynn Tumolo
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on...
02/29/2024
Pharmacy Learning Network
News
02/29/2024
Jolynn Tumolo
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose...
02/29/2024
Pharmacy Learning Network
News
02/29/2024
Jolynn Tumolo
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued...
02/29/2024
Pharmacy Learning Network

Advertisement